Study on the relationship between level of CD58 expression in peripheral blood mononuclear cell and severity of HBV infection

Chinese Medical Journal

Volumn 118, Issue 24, 2005, Pages 2072-2076

  Xie, Ming ^a   Wang, Xiang Ling ^a   Ji, Yu Qiang ^a   Li, Jie ^a   Meng, Zhao Jun ^a   Shi, Lin ^a   Yuan, Yu Kang ^a  

^a MEDICAL SCHOOL OF XI AN JIAOTONG UNIVERSITY   (China)

Author keywords

Antigen; CD58; Expression; Hepatitis B virus

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 3; MESSENGER RNA;

ANTIGEN EXPRESSION; ARTICLE; CELL ADHESION; CELL HYPERPLASIA; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; FLOW CYTOMETRY; HEPATITIS B; HUMAN; HUMAN CELL; LIVER INJURY; NATURAL KILLER CELL; PATIENT CODING; PERIPHERAL BLOOD MONONUCLEAR CELL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH2 CELL; BLOOD; GENETICS; METABOLISM; MONONUCLEAR CELL; PATHOPHYSIOLOGY;

ALANINE TRANSAMINASE; ANTIGENS, CD58; ASPARTATE AMINOTRANSFERASES; HEPATITIS B; HUMANS; LEUKOCYTES, MONONUCLEAR; RNA, MESSENGER;

EID: 33644851052     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Maddrey WC. Chronic hepatitis. Dis Mon 1993;39:53-125.
2. Oh S, Hodge JW, Ahlers JD, et al. Selective induction of high avidity CTL by altering the balance of signals from APC. J Immunol 2003;170:2523-2530.
3. Jiang RL, Feng XR, Guo YB, et al. T helper cells in patients with chronic hepatitis B virus infection. Chin Med J 2002;115:422-424.
4. + T cells. Cancer Immunol Immunother 2001; 49:629-640.
5. Jin BQ, Li ES, et al. A practical guide for basic immunology. Beijing:World Publishing Co., 1990:53-54.
6. + T cell and endothelial cell interactions upon chemokine production. Transplantation 2004;78:987-994.
7. Le Guiner S, Le Drean E, Labarriere N, et al. LFA-3 co-stimulates cytokine secretion by cytotoxic T lymphocytes by providing a TCR-independent activation signal. Eur J Immunol 1998;28:1322-1331.
8. Zhang DF. New progresses on therapies to hepatitis B virus. Chin J Hepatol (Chin) 1999;1:1-2.
9. 2 type cytokines responding to HBsAg and HBxAg in chronic hepatitis B patients. J Korean Med Sci 1999;14:175-181.
10. Autschbach F, Meuer SC, Moebius U, et al. Hepatocellular expression of lymphocyte function-associated antigen 3 in chronic hepatitis. Hepatology 1991;14:223-230.
11. + T-cell activation, protection from apoptosis, and enhanced cytokine production. Cell Immunol 2003;222:45-57.
12. Yue YF, Meng JL, Zhang SL. Mechanism of peripheral blood mononuclear cell invasion by HBV on artificial immunization in newborns. Chin Med J 2002;115:1380-1380.
13. Thompson CB. Apoptosis in the pathogenesis and treatment of disease. Science 1995;267:1456-1462.
14. Ito M, Watanabe M, Kamiya H, et al. Herpes simplex virus type 1 induces apoptosis in peripheral blood T lymphocytes. J Infect Dis 1997;75:1220-1224.
15. Li L, Gu CH, Li XW, et al. Fas expression and apoptosis of peripheral blood lymphocytes in patients with chronic hepatitis B and its significance. Acta Academiae Medicinae Militaris Tertiae 2001;23:712-715.
16. Bertoletti A. D'Elios MM, Boni C, et al. Different cytokine profiles of intrahepatic T cells in chronic hepatitis B and hepatitis C virus infection. Gastroenterology 1997;112:193-199.
17. Vingerhoets J, Michielsen P, Vanham G, et al. HBV-specific lymphoproliferative and cytokine responses in patients with chronic hepatitis B. J Hepatol 1998;28:8-16.
18. 58 (LFA-3). J Biol Regul Homeost Agents 2001; 15:190-192.
19. Elangbam CS, Qualls CW Jr, Dahlgren RR, et al. Cell adhesion molecules update. Vet Pathol 1997;34:61-73.
20. 59. Science 1992;256:1805-1807.
21. Jiang RL, Feng XR, Guo YB, et al. T helper cells in patients with chronic hepatitis B virus infection. Chin Med J 2002;115:422-424.
22. 2 ligand LFA-3 activates T cells but depends on the expression and function of the antigen receptor. J Immunol 1988;141:1904-1911.
23. Shaw S, Shimizu Y, et al. Two molecular pathways of human T cell adhesion: establishment of receptor-ligand relationship. Curr Opin Immunol 1988;1:92-97.
24. 2-LFA-3 interactions. Scand J Immunol 1988;28:277-284.
25. Parra E, Varga M, Hedlund G, et al. Costimulation by B7-1 and LFA-3 targets distinct nuclear factors that bind to the interleukin-2 promoter: B7-1 negatively regulates LFA-3-induced NF-AT DNA binding. Mol Cell Biol 1997;17:1314-1323.
26. + T cells. J Immunol 1997; 158:637-642.
27. 3 mAb to stimulate interferon gamma production in interleukin-2-activated T cells. Cancer Immunol Immunother 1994;39:127-134.
28. 2 signaling. J Immunol 1993;151:1328-1336.
29. 58 or CD48 with intercellular adhesion molecule 1 on target cells enhances adhesion of resting NK cells. J Immunol 2003;170:294-299.
30. Fletcher JM, Prentice HG, Grundy JE, et al. Natural killer cell lysis of cytomegalovirus (CMV)-infected cells correlates with virally induced changes in cell surface lymphocyte function-associated antigen-3 (LFA-3) expression and not with the CMV-induced down-regulation of cell surface class I HLA. J Immunol 1998;161:2365-2374.
31. Autschbach F, Meuer SC, Moebius U, et al. Hepatocellular expression of lymphocyte function-associated antigen 3 in chronic hepatitis. Hepatology 1991;14:223-230.
32. 58 interaction and the control of T-cell interleukin-12 responsiveness. Adhesion molecules link innate and acquired immunity. Ann N Y Acad Sci 1996;795:71-81.
33. 2 counter-receptors mediates the ability of monocytes to augment T cell activation by IL-12. J Immunol 1996; 157:1886-1893.
34. 2 regulates responsiveness of activated T cells to interleukin 12. J Exp Med 1995; 182:721-731.